Philip Bischoff

2.2k citations
60 papers · 1.4k indexed · 1 hit paper · h-index 17

Philip Bischoff

55 papers receiving 1.4k citations

Hit Papers

Causes of death and comorbidities in hospitalized patient...251202120262022202450100150200250

Peers

Philip Bischoff
Comparison fields: 5 of 125
  • Oncology 361
  • Infectious Diseases 187
  • Cancer Research 152
  • Immunology 209
  • Molecular Biology 590
Replace Vasileios Ragos with:
Vasileios Ragos Greece
Yanguang Cao United States
Luo Fang China
Chengshui Chen China
Francesco Torino Italy
Richard J. Honeywell Netherlands
Jianhua Chen China
Akintunde Bello United States
Maria Timofeeva United Kingdom
Philip Bischoff relative to Vasileios Ragos Greece Vasileios Ragos's profile →
Citations per field
00.5×2.6×
Vasileios Ragos · 1×
Citations per year

Countries citing papers authored by Philip Bischoff

Since Specialization
Citations

This map shows the geographic impact of Philip Bischoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Bischoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Bischoff more than expected).

Fields of papers citing papers by Philip Bischoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Bischoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Bischoff. The network helps show where Philip Bischoff may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Philip Bischoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip Bischoff Line = papers co-authored together Philip Bischoff links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20241
3 20244
4 20243
5 20231
6 20235
7 202324
8 20231
9 20235
10 20228
11 202218
12 2021131
13 202110
14 202028
15 202017
16 200214
17 200038
18 20008
19 199712
20 199545

About Philip Bischoff

Philip Bischoff is a scholar working on Aging, Developmental Neuroscience and Oncology, having authored 60 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (6 papers), Single-cell and spatial transcriptomics (5 papers), Cholesterol and Lipid Metabolism (5 papers), Radiation Therapy and Dosimetry (5 papers), Effects of Radiation Exposure (4 papers), Cancer Cells and Metastasis (4 papers), Cancer Genomics and Diagnostics (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). The work is most often cited by research in Oncology (361 citations), Infectious Diseases (187 citations) and Cancer Research (152 citations). Philip Bischoff has collaborated with scholars based in France, Germany and Belgium. Frequent co-authors include Karine Aupeix, B. Hugel, Holger Lill, Thierry Martin, J.‐L. Pasquali, David Horst, J M Freyssinet, Bang Luu, Marielle Christ and José Enrique Mejía. Their work appears in journals such as Canadian Journal of Physiology and Pharmacology, Radiation Research, International Journal of Cancer, British Journal of Cancer and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026